No protection of heart, kidneys and brain by remote ischemic preconditioning before transfemoral transcatheter aortic valve implantation: Interim-analysis of a randomized single-blinded, placebo-controlled, single-center trial

International Journal of Cardiology

Volumn 231, Issue , 2017, Pages 248-254

  Kahlert, Philipp ^a   Hildebrandt, Heike Annelie ^a   Patsalis, Polykarpos Christos ^a   Al Rashid, Fadi ^a   Jánosi, Rolf Alexander ^a   Nensa, Felix ^a   Schlosser, Thomas Wilfried ^a   Schlamann, Marc ^a,b   Wendt, Daniel ^a   Thielmann, Matthias ^a   Kottenberg, Eva ^a,c   Frey, Ulrich ^a   Neuhäuser, Markus ^a,d   Forsting, Michael ^a   Jakob, Heinz Günther ^a   Rassaf, Tienush ^a   Peters, Jürgen ^a   Heusch, Gerd ^a   Kleinbongard, Petra ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

^c Evangelisches Krankenhaus Mülheim   (Germany)

^d University for Applied Sciences   (Germany)

Author keywords

Brain; Cardioprotection; Heart; Kidney; RIPC; TAVI

Indexed keywords

TROPONIN I;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BRAIN PROTECTION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PROCEDURE; CAUSAL ATTRIBUTION; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; HEART INFARCTION; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REMOTE ISCHEMIC PRECONDITIONING; RENAL PROTECTION; SINGLE BLIND PROCEDURE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT DURATION; AGED; AORTIC VALVE STENOSIS; BRAIN; CATHETERIZATION; CINE MAGNETIC RESONANCE IMAGING; ELECTIVE SURGERY; FEMALE; FEMORAL ARTERY; FOLLOW UP; GERMANY; HEART; HEART INFARCTION PREVENTION; INCIDENCE; KIDNEY; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROCEDURES; PROSPECTIVE STUDY; SURVIVAL RATE; TRENDS; UNNECESSARY PROCEDURE;

ACUTE KIDNEY INJURY; AGED; AORTIC VALVE STENOSIS; BRAIN; CATHETERIZATION, PERIPHERAL; ELECTIVE SURGICAL PROCEDURES; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; GERMANY; HEART; HUMANS; INCIDENCE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; KIDNEY; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREOPERATIVE CARE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; STROKE; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE REPLACEMENT; UNNECESSARY PROCEDURES;

EID: 85008208926     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.12.005     Document Type: Article

References (32)

1. [1] Kapadia, S.R., Leon, M.B., Makkar, R.R., et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385 (2015), 2485–2491.
2. [2] Mack, M.J., Leon, M.B., Smith, C.R., et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385 (2015), 2477–2484.
3. [3] Rodes-Cabau, J., Gutierrez, M., Bagur, R., et al. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J. Am. Coll. Cardiol. 57 (2011), 1988–1999.
4. [4] Gargiulo, G., Sannino, A., Capodanno, D., et al. Impact of postoperative acute kidney injury on clinical outcomes after transcatheter aortic valve implantation: a meta-analysis of 5,971 patients. Catheter. Cardiovasc. Interv. 86 (2015), 518–527.
5. [5] Eggebrecht, H., Schmermund, A., Voigtlander, T., Kahlert, P., Erbel, R., Mehta, R.H., Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 8 (2012), 129–138.
6. [6] Kahlert, P., Knipp, S.C., Schlamann, M., et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 121 (2010), 870–878.
7. [7] Heusch, G., Bøtker, H.E., Przyklenk, K., Redington, A., Yellon, D., Remote ischemic conditioning. J. Am. Coll. Cardiol. 65 (2015), 177–195.
8. [8] Heusch, G., Rassaf, T., Time to give up on cardioprotection? A critical appraisal of clinical studies on ischemic pre-, post-, and remote conditioning. Circ. Res. 119 (2016), 676–695.
9. [9] Bøtker, H.E., Kharbanda, R., Schmidt, M.R., et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375 (2010), 727–734.
10. [10] Eitel, I., Stiermaier, T., Rommel, K.P., et al. Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial. Eur. Heart J. 36 (2015), 3049–3057.
11. [11] Yellon, D.M., Ackbarkhan, A.K., Balgobin, V., et al. Remote ischemic conditioning reduces myocardial infarct size in STEMI patients treated by thrombolysis.[letter]. J. Am. Coll. Cardiol. 65:25 (2015), 2764–2765.
12. [12] Hoole, S.P., Heck, P.M., Sharples, L., et al. Cardiac remote ischemic preconditioning in coronary stenting (CRISP stent) study: a prospective, randomized control trial. Circulation 119 (2009), 820–827.
13. [13] Hausenloy, D.J., Mwamure, P.K., Venugopal, V., et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 370 (2007), 575–579.
14. [14] Thielmann, M., Kottenberg, E., Kleinbongard, P., et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet 382 (2013), 597–604.
15. [15] Candilio, L., Malik, A., Ariti, C., et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart 101 (2015), 185–192.
16. [16] Sloth, A.D., Schmidt, M.R., Munk, K., et al. Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. Eur. Heart J. 35 (2014), 168–175.
17. [17] Davies, W.R., Brown, A.J., Watson, W., et al. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up. Circ. Cardiovasc. Interv. 6 (2013), 246–251.
18. [18] Meybohm, P., Bein, B., Brosteanu, O., et al. A multicenter trial of remote ischemic preconditioning for heart surgery. N. Engl. J. Med. 373 (2015), 1397–1407.
19. [19] Hausenloy, D.J., Candilio, L., Evans, R., et al. Remote ischemic preconditioning and outcomes of cardiac surgery. N. Engl. J. Med. 373 (2015), 1408–1417.
20. [20] Kottenberg, E., Thielmann, M., Bergmann, L., et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial. Acta Anaesthesiol. Scand. 56 (2012), 30–38.
21. [21] Zangrillo, A., Musu, M., Greco, T., et al. Additive effect on survival of anaesthetic cardiac protection and remote ischemic preconditioning in cardiac surgery: a Bayesian network meta-analysis of randomized trials. PLoS One, 10, 2015, e0134264.
22. [22] Kappetein, A.P., Head, S.J., Genereux, P., et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document. J. Am. Coll. Cardiol. 60 (2012), 1438–1454.
23. [23] Kahlert, P., Al-Rashid, F., Plicht, B., et al. Myocardial injury during transfemoral transcatheter aortic valve implantation: an intracoronary Doppler and cardiac magnetic resonance imaging study. EuroIntervention 11 (2016), 1401–1408.
24. [24] Heusch, G., Cardioprotection: chances and challenges of its translation to the clinic. Lancet 381 (2013), 166–175.
25. [25] Newman, M.F., Ferguson, T.B., White, J.A., et al. Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial. JAMA 308 (2012), 157–164.
26. [26] Milei, J., Forcada, P., Fraga, C.G., et al. Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion. Cardiovasc. Res. 73 (2007), 710–719.
27. [27] Sinning, J.M., Hammerstingl, C., Schueler, R., et al. The prognostic value of acute and chronic troponin elevation after transcatheter aortic valve implantation. EuroIntervention 11 (2016), 1522–1529.
28. [28] Thielmann, M., Massoudy, P., Schmermund, A., et al. Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery. Eur. Heart J. 26 (2005), 2440–2447.
29. [29] Zarbock, A., Schmidt, C., Van Aken, H., et al. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA 313 (2015), 2133–2141.
30. [30] Hess, D.C., Blauenfeldt, R.A., Andersen, G., et al. Remote ischaemic conditioning-a new paradigm of self-protection in the brain. Nat. Rev. Neurol. 11 (2015), 698–710.
31. [31] Hougaard, K.D., Hjort, N., Zeidler, D., et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke 45 (2014), 159–167.
32. [32] Haussig, S., Mangner, N., Dwyer, M.G., et al. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial. JAMA 316 (2016), 592–601.